Delta Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.32M Sell
6,305
-384
-6% -$74.7K 0.3% 60
2024
Q4
$1.19M Sell
6,689
-90
-1% -$16.5K 0.28% 62
2024
Q3
$1.34M Buy
6,779
+34
+0.5% +$6.35K 0.5% 32
2024
Q2
$1.16M Buy
6,745
+24
+0.4% +$3.98K 0.49% 31
2024
Q1
$1.22M Buy
6,721
+85
+1% +$14.6K 0.36% 52
2023
Q4
$1.03M Sell
6,636
-523
-7% -$76.2K 0.32% 58
2023
Q3
$1.07M Buy
7,159
+536
+8% +$78.7K 0.37% 53
2023
Q2
$892K Buy
6,623
+866
+15% +$127K 1.05% 30
2023
Q1
$917K Buy
5,757
+68
+1% +$10.4K 0.36% 47
2022
Q4
$927K Buy
+5,689
New +$872K 0.41% 45

Other funds holding ABBV

Delta Financial Group's ABBV Position: Q1 2025 in Review

Delta Financial Group reduced its AbbVie (ABBV) stake by 5.7% in Q1 2025, selling an estimated $74.7K and leaving 6,305 shares worth $1.32M. The position accounts for 0.3% of the portfolio, ranked #60.

Delta Financial Group first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.34M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Delta Financial Group held 6,305 shares of AbbVie worth $1.32M as of Q1 2025.
  • Delta Financial Group sold 384 AbbVie shares in Q1 2025, an estimated $74.7K.
  • AbbVie made up 0.3% of Delta Financial Group's portfolio in Q1 2025, its #60 holding.
  • Delta Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
  • Delta Financial Group's AbbVie position peaked at $1.34M in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.